BIDMC Cancer Center
@bidmc-cancercenter.bsky.social did:plc:45bljdctrgtpxjgjdgogt6oo
We better the lives of patients with cancer, leveraging transformative science and pioneering therapies to provide highly personalized and compassionate care accessible to all.
Bluesky’a katılma tarihi:
- Takipçi
- 425
- Takip edilen
- 14
- Post
- 204
- Sıralamaya girdiği gün
- 0
Özet
BIDMC Cancer Center (@bidmc-cancercenter.bsky.social), 18 Kasım 2024 tarihinde katılan bir Bluesky kullanıcısı. 425 takipçisi var, 14 hesabı takip ediyor ve 204 post paylaştı.
Sıralama geçmişi
Bu hesabın postlarının Debya günlük listesine girdiği en iyi günler.
Bu hesap henüz günlük sıralamaya girmedi.
Son beğendiği postlar
Bluesky ağındaki herkese açık beğeniler.
💡Our real-world analysis showed median time to consolidative #immunotherapy of 84 days from CRT start in Stage III #NSCLC (2018-2021). Uninsured, Medicaid, and tx at non-academic center associated w/ longer time to intiation #ASCOQLTY26 @bidmc-cancercenter.bsky.social @ascocancer.bsky.social
Postu gösterOur paper is finally out! We discovered that FAH is enriched in HR+ breast cancer where it drives treatment resistance via a novel non-canonical function
Postu gösterThe Plenary Session at the American Society for Radiation Oncology (ASTRO) Annual Meeting 2026 has ended. Experts are now answering questions on Mednet. Head to the Q&A → gqr.sh/QpfP #ASTRO26 #RadOnc #ClinicalTrials #CancerResearch #MedEd
Postu gösterPRESS RELEASE: NRG Oncology Trial Results Show No Survival Benefit with the Use of Proton Therapy for Patients with Advanced Hepatocellular Carcinoma #ASTRO26 - Read the Release: https://ow.ly/Nm8C50ZPKWZ
Postu gösterNOW AVAILABLE! Join us as we break down the results of NRG-CC009 and NRG-GI003 presented in the #ASTRO26 Plenary Session. Find the NRG Oncology Podcast on Spotify, Apple Podcasts, Amazon, YouTube and stream www.NRGOncology.org/Podcast
Postu göster
Blokladığı hesaplar
Bluesky’da bloklar herkese açık kayıtlardır.
Bu hesap kimseyi bloklamıyor.